| 出版社 | MarketsandMarkets |
| 出版年月 | 2025年3月 |
Assisted Reproductive Technology Market – Global Forecast to 2030
The assisted reproductive technology market is projected to reach USD 6.02 Billion by 2030 from USD 4.29 Billion in 2025 at a CAGR of 7.0% during the forecast period.
生殖補助医療（ART）市場は、予測期間中に年平均成長率 7.0% で成長し、2025 年の 42 億 9,000 万米ドルから 2030 年までに 60 億 2,000 万米ドルに達すると予測されています。
Increasing rates of infertility due to delayed conception, altered lifestyles, and growing awareness of fertility treatment are driving the assisted reproductive technology (ART) market. Further impetus to market growth is coming from improvements in medical technology, improved treatment success rates with in-vitro fertilization (IVF), and favorable government policies. But some of these limitations are the cost of treatment, ethical and legal issues, and health risks associated with ART procedures. Inadequacy of fertility treatment in developing nations and physical and psychological stress of ART also limit market growth. Research and development are, in spite of these limitations, enhancing the price and effectiveness of ART treatments.
受胎の遅れ、ライフスタイルの変化、不妊治療に対する意識の高まりによる不妊率の上昇が、生殖補助医療 (ART) 市場の牽引役となっています。医療技術の向上、体外受精 (IVF) による治療成功率の向上、政府の好ましい政策も、市場の成長を後押ししています。しかし、治療費、倫理的および法的問題、ART 処置に伴う健康リスクなど、こうした制約もあります。発展途上国における不妊治療の不十分さや、ART による身体的および精神的ストレスも、市場の成長を制限しています。こうした制約にもかかわらず、研究開発により、ART 治療の価格と効果は向上しています。
assisted-reproductive-technology-market-Ecosystem
Prominent players in this market include CooperSurgical Inc. (US), FUJIFILM Irvine Scientific (Japan), Vitrolife (Sweden), Hamilton Thorne (US), Cook Medical Inc. (US), Esco Micro Pte. Ltd. (Singapore), Genea BIOMEDX (Australia), Thermo Fisher Scientific Inc. (US), LENUS Pharma GesmbH (Austria), Zita West (UK), Kitazato Corporation (Japan), Exeltis USA, Inc. (US), Vitabiotics Ltd (UK), FertiPro NV (Belgium), and AdvaCare Pharma (US), among others.
This report provides insights on:
- Analysis of Market Dynamics: Drivers (Increasing median age of pregnancy, Rising infertility rate, Booming fertility industry, Evolving technological landscape, Favorable government initiatives) restraints (High cost of IVF procedures, Social and ethical concerns in developing countries, Elevated risk of complications) opportunities (Growth opportunities in emerging economies, Availability of diverse range of fertility treatment options), and challenges (Reduced efficacy of infertility treatments among patients of advanced age)
- Services/Innovations: Detailed insights on upcoming technologies, research & development activities, and new product launches in the assisted reproductive technology market.
- Market Development: Comprehensive information on the lucrative emerging markets, components, demographics, care settings, and region.
- Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the assisted reproductive technology market.
- Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the assisted reproductive technology market like CooperSurgical Inc. (US), FUJIFILM Irvine Scientific (Japan), Vitrolife (Sweden), Hamilton Thorne (US), Cook Medical Inc. (US), Esco Micro Pte. Ltd. (Singapore), Genea BIOMEDX (Australia), and Thermo Fisher Scientific Inc. (US).